EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   1.8.3.5 | Acquired Immunodeficiency Syndrome |
27684403 |
Modulation of MMP-2 and MMP-9 through connected pathways and growth factors is critical for extracellular matrix balance of intra-articular ligaments. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 1.8.3.5 | Activated Protein C Resistance |
16416115 |
Plasma cell leukemia: a rare condition. |
causal interaction
unassigned |
1
0 |
| 1.8.3.5 | Adenocarcinoma |
19666094 |
Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 1.8.3.5 | Adenocarcinoma |
28511234 |
Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated January 2017. |
unassigned |
0 |
| 1.8.3.5 | Adenolymphoma |
10860329 |
Differentiating HIV-1 parotid cysts from papillary cystadenoma lymphomatosum. |
causal interaction
therapeutic application
unassigned |
2
4
0 |
| 1.8.3.5 | Airway Obstruction |
25823699 |
Therapeutic options for hydrating airway mucus in cystic fibrosis. |
causal interaction
unassigned |
1
0 |
| 1.8.3.5 | Anemia |
10626149 |
Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. |
diagnostic usage
unassigned |
1
0 |
| 1.8.3.5 | Anemia |
12780792 |
Prevalence and prognostic significance of sMUC-1 levels in plasma cell dyscrasias. |
causal interaction
diagnostic usage
unassigned |
3
4
0 |
| 1.8.3.5 | Anemia |
15609327 |
Bortezomib is an efficient agent in plasma cell leukemias. |
unassigned |
0 |
| 1.8.3.5 | Anemia |
25418598 |
[Plasma cell leukemia]. |
unassigned |
0 |
